In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of Vector Group Ltd.
(NYSE:VGR), NovoCure Limited (NASDAQ:NVCR), ORBCOMM Inc.
(NASDAQ:ORBC), Ecolab Inc. (NYSE:ECL), Bank of America Corporation
(NYSE:BAC), and Viking Therapeutics, Inc. (NASDAQ:VKTX), including
updated fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
VGR DOWNLOAD:
http://Fundamental-Markets.com/register/?so=VGR
NVCR DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NVCR
ORBC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ORBC
ECL DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ECL
BAC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BAC
VKTX DOWNLOAD:
http://Fundamental-Markets.com/register/?so=VKTX
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above, examine
Vector Group Ltd. (NYSE:VGR), NovoCure Limited (NASDAQ:NVCR),
ORBCOMM Inc. (NASDAQ:ORBC), Ecolab Inc. (NYSE:ECL), Bank of America
Corporation (NYSE:BAC), and Viking Therapeutics, Inc. (NASDAQ:VKTX)
on a fundamental level and outlines the overall demand for their
products and services in addition to an in-depth review of the
business strategy, management discussion, and overall direction
going forward. Several excerpts from the recently released reports
are available to today's readers below.
-----------------------------------------
Important Notice: the following
excerpts are not designed to be standalone summaries and as such,
important information may be missing from these samples. All
information in this release was accessed November 19th, 2017.
Please download the entire research report, free of charge, to
ensure you are reading all relevant material information. All
amounts in millions (except per share amounts).
-----------------------------------------
VECTOR GROUP LTD. (VGR) REPORT OVERVIEW
Vector Group's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Vector Group reported revenue of $484.63
vs $459.10 (up 5.56%) and diluted earnings per share $0.13 vs $0.17
(down 23.53%). For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Vector Group reported revenue of $1,690.95 vs
$1,657.20 (up 2.04%) and diluted earnings per share $0.52 vs $0.44
(up 19.56%). Vector Group is expected to report earnings on March
7th, 2018. The report will be for the fiscal period ending December
31st, 2017. The reported EPS for the same quarter last year was
$0.12. The estimated EPS forecast for the next fiscal year is $0.66
and is expected to report on March 7th, 2018.
To read the full Vector Group Ltd. (VGR) report, download it
here:
http://Fundamental-Markets.com/register/?so=VGR
-----------------------------------------
NOVOCURE LIMITED (NVCR) REPORT OVERVIEW
NovoCure's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, NovoCure reported revenue of $50.11 vs
$21.67 (up 131.19%) and diluted earnings per share -$0.13 vs
-$0.39. For the twelve months ended December 31st, 2016 vs December
31st, 2015, NovoCure reported revenue of $82.89 vs $33.09 (up
150.52%) and diluted earnings per share -$1.54 vs -$3.67. NovoCure
is expected to report earnings on February 22nd, 2018. The report
will be for the fiscal period ending December 31st, 2017. The
reported EPS for the same quarter last year was -$0.26. The
estimated EPS forecast for the next fiscal year is -$0.36 and is
expected to report on February 22nd, 2018.
To read the full NovoCure Limited (NVCR) report, download it
here:
http://Fundamental-Markets.com/register/?so=NVCR
-----------------------------------------
ORBCOMM INC. (ORBC) REPORT OVERVIEW
ORBCOMM's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, ORBCOMM reported revenue of $69.37 vs
$46.29 (up 49.86%) and diluted earnings per share -$0.54 vs -$0.20.
For the twelve months ended December 31st, 2016 vs December 31st,
2015, ORBCOMM reported revenue of $186.74 vs $178.29 (up 4.74%) and
diluted earnings per share -$0.33 vs -$0.19. ORBCOMM is expected to
report earnings on February 27th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was -$0.04. The estimated EPS forecast for
the next fiscal year is -$0.15 and is expected to report on
February 27th, 2018.
To read the full ORBCOMM Inc. (ORBC) report, download it here:
http://Fundamental-Markets.com/register/?so=ORBC
-----------------------------------------
ECOLAB INC. (ECL) REPORT OVERVIEW
Ecolab's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Ecolab reported revenue of $3,563.30 vs
$3,386.10 (up 5.23%) and diluted earnings per share $1.34 vs $1.27
(up 5.51%). For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Ecolab reported revenue of $13,152.80 vs
$13,545.10 (down 2.90%) and diluted earnings per share $4.14 vs
$3.32 (up 24.70%). Ecolab is expected to report earnings on
February 20th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter
last year was $1.25. The estimated EPS forecast for the next fiscal
year is $5.33 and is expected to report on February 20th, 2018.
To read the full Ecolab Inc. (ECL) report, download it here:
http://Fundamental-Markets.com/register/?so=ECL
-----------------------------------------
BANK OF AMERICA CORPORATION (BAC) REPORT
OVERVIEW
Bank of America's Recent Financial
Performance
Bank of America is expected to report earnings
on January 12th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter
last year was $0.40. The estimated EPS forecast for the next fiscal
year is $2.13 and is expected to report on January 12th, 2018.
To read the full Bank of America Corporation (BAC) report,
download it here:
http://Fundamental-Markets.com/register/?so=BAC
-----------------------------------------
VIKING THERAPEUTICS, INC. (VKTX) REPORT
OVERVIEW
Viking Therapeutics' Recent Financial
Performance
Viking Therapeutics is expected to report
earnings on March 20th, 2018. The report will be for the fiscal
period ending December 31st, 2017. The reported EPS for the same
quarter last year was -$0.18. The estimated EPS forecast for the
next fiscal year is -$0.72 and is expected to report on March 20th,
2018.
To read the full Viking Therapeutics, Inc. (VKTX) report,
download it here:
http://Fundamental-Markets.com/register/?so=VKTX
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets' Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail:
andrew.duffie@fundamental-markets.com
Ⓒ 2017 Fundamental Markets. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Vector (NYSE:VGR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vector (NYSE:VGR)
Historical Stock Chart
From Sep 2023 to Sep 2024